GGTase-I α Antibodies

Santa Cruz Biotechnology features a diverse variety of GGTase-I α monoclonal antibodies for research applications. GGTase-I α monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GGTase-I α, or geranylgeranyltransferase type I alpha, plays a crucial role in the post-translational modification of proteins, specifically in the addition of geranylgeranyl groups to certain proteins, which is essential for their proper localization and function. The enzyme is important in various cellular processes, including signal transduction and cell growth, making it a significant target in cancer research and other diseases. Understanding GGTase-I α function can provide insights into the mechanisms of oncogenesis and potential therapeutic strategies. Research has shown that GGTase-I α activity is frequently dysregulated in various cancer types, highlighting its importance as a therapeutic target. Investigating GGTase-I α expression patterns and interactions can reveal new pathways involved in disease progression. The development of targeted therapies focusing on GGTase-I α regulation continues to be an active area of research. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of GGTase-I α and its role in human health and disease.